Decreases in the Serum VLDL-TG/Non-VLDL-TG Ratio from Early Stages of Chronic Hepatitis C: Alterations in TG-Rich Lipoprotein Levels
2011

Changes in Lipoprotein Levels in Chronic Hepatitis C

Sample size: 119 publication Evidence: moderate

Author Information

Author(s): Nishimura Motoi, Yamamoto Haruna, Yoshida Toshihiko, Seimiya Masanori, Sawabe Yuji, Matsushita Kazuyuki, Umemura Hiroshi, Sogawa Kazuyuki, Takizawa Hirotaka, Yokosuka Osamu, Nomura Fumio

Primary Institution: Chiba University, Chiba City, Japan

Hypothesis

Does the serum VLDL-TG/non-VLDL-TG ratio change in patients with chronic hepatitis C?

Conclusion

The study found that the serum VLDL-TG/non-VLDL-TG ratio decreases as early as stage F1 of chronic hepatitis C, indicating alterations in triglyceride metabolism.

Supporting Evidence

  • Serum VLDL-TG levels were significantly lower in patients with non-cirrhotic chronic hepatitis C compared to healthy subjects.
  • The serum VLDL-TG/non-VLDL-TG ratio decreased significantly from stage F1 onward in chronic hepatitis C patients.
  • Total triglyceride levels did not show significant differences between patients and healthy subjects until cirrhosis.

Takeaway

This study shows that people with chronic hepatitis C have changes in certain fats in their blood, which can help doctors understand how the disease is progressing.

Methodology

The study measured serum VLDL-TG levels in 69 patients with chronic hepatitis C and 50 healthy subjects using a new assay protocol.

Limitations

Healthy subjects did not undergo liver biopsy to confirm normal liver function.

Participant Demographics

69 patients with chronic hepatitis C and 50 healthy subjects, with no history of excessive alcohol or drug abuse.

Statistical Information

P-Value

p<0.000001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0017309

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication